Nu Skin Enterprises, Inc. (NYSE:NUS) saw some unusual options trading activity on Thursday. Investors acquired 16,027 put options on the company. This represents an increase of approximately 1,766% compared to the average volume of 859 put options.
Shares of Nu Skin Enterprises (NYSE:NUS) traded up 3.16% during trading on Friday, reaching $55.48. 995,807 shares of the company’s stock were exchanged. Nu Skin Enterprises has a 52-week low of $46.35 and a 52-week high of $66.04. The company has a 50 day moving average of $61.67 and a 200 day moving average of $56.55. The firm has a market capitalization of $2.94 billion, a P/E ratio of 18.56 and a beta of 1.31.
Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Wednesday, August 2nd. The company reported $0.77 earnings per share for the quarter, beating analysts’ consensus estimates of $0.69 by $0.08. Nu Skin Enterprises had a net margin of 7.53% and a return on equity of 24.14%. The firm had revenue of $550.10 million during the quarter, compared to the consensus estimate of $548.09 million. During the same period in the prior year, the firm earned $0.79 EPS. The business’s revenue was down 8.4% on a year-over-year basis. Equities analysts anticipate that Nu Skin Enterprises will post $3.23 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 13th. Shareholders of record on Friday, August 25th will be issued a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a yield of 2.60%. The ex-dividend date is Wednesday, August 23rd. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 48.81%.
Several equities analysts recently weighed in on NUS shares. Zacks Investment Research upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating and set a $63.00 target price on the stock in a report on Wednesday, April 26th. Sidoti lowered shares of Nu Skin Enterprises from a “buy” rating to a “neutral” rating and set a $59.00 target price on the stock. in a report on Wednesday, April 26th. Pivotal Research restated a “buy” rating and set a $65.00 target price on shares of Nu Skin Enterprises in a report on Thursday, May 4th. ValuEngine upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Finally, Deutsche Bank AG lifted their target price on shares of Nu Skin Enterprises from $63.00 to $66.00 and gave the company a “buy” rating in a report on Wednesday, June 21st. Two research analysts have rated the stock with a sell rating, two have assigned a hold rating and six have given a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of $62.88.
In other Nu Skin Enterprises news, General Counsel D Matthew Dorny sold 8,000 shares of Nu Skin Enterprises stock in a transaction on Monday, June 5th. The shares were sold at an average price of $56.39, for a total value of $451,120.00. Following the transaction, the general counsel now owns 52,730 shares in the company, valued at approximately $2,973,444.70. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In the last quarter, insiders sold 31,750 shares of company stock worth $1,946,810. 5.20% of the stock is owned by company insiders.
Hedge funds have recently modified their holdings of the stock. BlackRock Inc. increased its stake in shares of Nu Skin Enterprises by 21,593.4% in the first quarter. BlackRock Inc. now owns 6,683,531 shares of the company’s stock worth $371,201,000 after buying an additional 6,652,722 shares during the period. Credit Suisse AG increased its stake in shares of Nu Skin Enterprises by 64.9% in the first quarter. Credit Suisse AG now owns 122,216 shares of the company’s stock worth $6,788,000 after buying an additional 48,082 shares during the period. Algert Global LLC bought a new stake in shares of Nu Skin Enterprises during the first quarter worth $623,000. Highland Capital Management LLC bought a new stake in shares of Nu Skin Enterprises during the first quarter worth $313,000. Finally, Liberty Mutual Group Asset Management Inc. bought a new stake in shares of Nu Skin Enterprises during the first quarter worth $1,235,000. 84.53% of the stock is owned by hedge funds and other institutional investors.
ILLEGAL ACTIVITY NOTICE: “Traders Buy High Volume of Put Options on Nu Skin Enterprises (NUS)” was published by BNB Daily and is the property of of BNB Daily. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://www.baseball-news-blog.com/2017/08/19/nu-skin-enterprises-sees-unusually-high-options-volume-nus-updated-updated-updated.html.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.
Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with MarketBeat.com's FREE daily email newsletter.